AbstractObjectivesThe purpose of this study was to investigate the effects of 56 herbal formulae covered by the National Health Insurance Corporation (NHIC) on dementia-related biomarkers and neuronal cell changes.
MethodsThe 56 herbal formulae were extracted with 70% ethanol at 100°C for 2 h. The antioxidant properties was measured by radical scavenging assay using ABTS+ radical. The acetylcholinesterase (AChE) activity was tested by Ellman’s assay and amyloid-β (Aβ) aggregation was determined using fluorescence method. To estimate the inhibitory effects of herbal formulae on neuronal cell death and inflammation using HT22 hippocampal cells and BV-2 microglia, respectively.
ResultsAmong the 56 herbal formulae, Dangguiyukhwangtang, Banhasasimtang, Samhwangsasimtang, Cheongwiesan, Hwangryunhaedoktang, Banhabaekchulchunmatang, Jaeumganghwatang, Cheongseoikgitang, and Hoechunyanggyuksan has a significant inhibitory effects on acetylcholinesterase (AChE) activity. Doinseunggitang and Samhwangsasimtang exerted the effect on the inhibition of amyloid-β (Aβ) aggregation. Additionally, 10 herbal formulae affected AChE and Aβ aggregation revealed antioxidant activity as well as neuroprotective and anti-neuroinflammation effects in neuronal cell lines.
Conclusions10 herbal formulae that have been shown to be effective against the major dementia markers have been shown to have antioxidant activity, neuronal cell protection and inhibition of brain inflammation. Further investigation of these herbal formulae will need to be validated in dementia animal models.
참고문헌1. Son, CH, Kim, YH, & Lim, S. A Study on Korean Oriental Medical Doctors’ Use of Uninsured Herbal Extracts and How to Promote the Insurance Coverage of Such Herbal Extracts. J Korean Oriental Med, (2009). 30(4), 64-78.
3. Akhondzadeh, S, & Abbasi, SH. Herbal medicine in the treatment of Alzheimer’s disease. Am J Alzheimers Dis Other Demen, (2006). 21(2), 113-8.
![]() ![]() 4. Cho, HY, Hong, SS, Whang, WW, & Cho, SH. A Retrospective Study on Dementia Outpatients in Oriental Neuropsychiatry Clinic of One Medical Center. J of Oriental Neuropsychiatry, (2010). 21( 4), 137-49.
5. Kim, BG, Hyun, KC, Kim, JW, & Whang, WW. A Clinical Study on the Effects of Oriental Medical Treatment on Dementia of Alzheimer type. J of Oriental Neuropsychiatry, (1998). 9(1), 25-43.
6. Terasawa, K, Shimada, Y, Kita, T, Yamamoto, T, Tosa, H, & Tanaka, N, et al. Choto-san in the treatment of vascular dementia: a double-blind, placebo-controlled study. Phytomedicine, (1997). 4( 1), 15-22.
![]() ![]() 7. Matsuda, Y, Kishi, T, Shibayama, H, & Iwata, N. Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol, (2013). 28(1), 80-6.
![]() ![]() 8. Lim, HS, Kim, Y, Kim, OS, & Jeong, SJ. Screening of 50 Korean Herbal formulas with Inhibitory Effects on Acetylcholinesterase Activity and Amyloid-β Aggregation. Kor J Pharmacogn, (2016). 47(3), 287-294.
10. Lim, HS, Ha, H, Seo, CS, Jin, SE, Kim, Y, & Jeon, WY, et al. Comparative study on efficacies and ingredient contents of different solvent extracts of Insampaedok-san. Kor J Herbology, (2012). 27( 6), 115-122.
![]() 11. Ellman, GL, Courtney, KD, Andres, V, & Feather-Stone, RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, (1961). 7, 88-95.
![]() ![]() 12. Habtemariam, S. The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer’s disease therapy. Nat Prod Commun, (2011). 6(8), 1089-90.
![]() 13. Hellstrand, E, Boland, B, Walsh, DM, & Linse, S. Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci, (2010). 1, 13-8.
![]() ![]() ![]() 14. Lemkul, JA, & Bevan, DR. Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce “off-pathway” structures. Biochemistry, (2012). 51(30), 5990-6009.
![]() ![]() 15. Re, R, Pellegrini, N, Proteggente, A, Pannala, A, Yang, M, & Rice-evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med, (1999). 26, 1231-7.
![]() ![]() 16. Prince, M, Ali, GC, Guerchet, M, Prina, AM, Albanese, E, & Wu, YT. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimers Res Ther, (2016). 8(1), 23.
![]() ![]() ![]() 17. Raina, P, Santaguida, P, Ismaila, A, Patterson, C, Cowan, D, & Levine, M, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med, (2008). 148(5), 379-97.
![]() ![]() 18. Naik, RS, Hartmann, J, Kiewert, C, Duysen, EG, Lockridge, O, & Klein, J. Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice. J Pharm Pharm Sci, (2009). 12, 79-85.
![]() ![]() 19. Ames, BN, Shigenaga, MK, & Hagen, TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA, (1993). 90, 7915-7922.
![]() ![]() ![]() 20. Koo, JS, Seo, BI, Park, JH, & Roh, SS. Analysis of papers on Oriental herbal medicines(prescriptions and herbs) for dementia. Kor J Herbology, (2010). 25, 131-137.
21. Kim, W, Jeon, W, Heo, E, Park, S, & Han, C. Literature review and suggestions: dementia clinical studies in Korean Oriental Medicine. Kor J Orient Med, (2011). 17, 39-46.
22. Vetrivel, KS, & Thinakaran, G. Amyloidogenic processing of betaamyloid precursor protein in intracellular compartments. Neurology, (2006). 66, S69-73.
![]() ![]() 23. Eikelenboom, P, & van Gool, WA. Neuroinflammatory perspectives on the two faces of Alzheimer’s disease. J Neural Transm, (2004). 111, 281-94.
![]() ![]() 24. Liu, B, & Hong, JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther, (2003). 304, 1-7.
![]() ![]() 26. Hsu, YL, Kuo, PI, Tzeng, TF, Sung, SC, Yen, MH, & Lin, YT, et al. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. J Gastroenterol Hepatol, (2008). 23, e290-9.
![]() ![]() 27. Lu, J, Wang, JS, & Kong, LY. Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds. J Ethnopharmacol, (2011). 134, 911-8.
![]() ![]() 28. Sasaki, K, Sudo, T, Kurusu, T, Kiuchi, T, & Yoshizaki, F. The mechanism of alteration of monoamine metabolism in brain regions in marble burying behavior-isolated housing mice and effect of oren-gedoku-to on this alteration. Yakugaku Zasshi, (2000). 120(6), 559-67.
![]() ![]() 29. Chung, SY, Kim, JW, Lee, JR, Jang, HH, Kim, HT, & Whang, WW. The Effects of Whangryonghaedoktang on Morris Water Maze and Tyrosine Hydroxylase Expression in Ventral Tegmental Area and Locus Coeruleus of the Chronic Mild Stress Animal Model of Depression. J of Oriental Neuropsychiatry, (2003). 14(1), 1-16.
30. Guoxin, DU, Shangqin, LIU, Xiaoxi, XIE, Li, HE, Xiaoling, ZHU, & Wenyu, RONG, et al. The efficacy of Huang-Lian-Jie-Du-Tang combined with chemotherapy for multiple myeloma. J Clinical Hematology, (2012). 25(5), 306-8.
31. Sao, L, Goto, K, Shimada, Y, & Terasawa, Y. Clinical comparative study of Huangyang detoxification hot water boiled rhubarb and atorvastatin for hyperlipidemia: including diet control, comparison with Placebo. Japan Toyo Kagaku Journal, (2004). 55, 236.
32. Tohru, S. Significance of Combined Use of Huangyaku Toxin for Insomnia in Manic Condition. Journal of Japan Toyo Medical Journal, (2004). 55, 179.
33. Kim, HY, Shin, SH, & Lee, I. Neuroprotective Effect of Hwangryunhaedok-tang Against Glucose-deprivation Induced Cytotoxicity in PC-12 Cells. Korean J Oriental Physiology & Pathology, (2008). 22(6), 1462-9.
34. Qing, F, Xiaoping, Z, Jianwei, M, & Mei, S. The therapeutic effect of Huanglian Jiedu Decoction on AD rats and its effect on cytokine content. J of Tradit Chin Med, (2004). 29(6), 575-8.
35. Qiu, Y, Chen, G, Mei, G, Wang, W, Wang, K, & Pan, S. Effect of Huanglian Jiedu Decoction on free radical metabolism and IL-6, IL-1β content in brain tissue of mice with APP/PS1 double transgenic Alzheimer’s disease. Stroke and neurological diseases, (2011). 18(2), 72-4.
36. Chen, G, Shan, P, & Qiu, Y. Clinical study of Huanglian Jiedu Decoction in the treatment of senile dementia (Heart and Liver). Chinese Journal of Emergency Medicine, (2007). 16(4), 386-7.
38. Lee, JY, & Kook, YB. Effects of Samhwangsasim-tang on obesity-related metabolic disease in mice. Herbal formula science, (2014). 22(1), 93-104.
![]() 39. Lee, HC, Jeong, MY, Choi, JH, & Park, SY. Effects of Samhwangsasim-tang Gamibang on Atopic Dermatitis in Mice. Herbal formula science, (2017). 25(3), 337-47.
40. Koo, JS, Kwon, DK, Seo, BI, Park, JH, Roh, SS, & Kim, SM, et al. The Antimicrobial Activity of Samhwangsasimtang against pseudomonas aeruginosa 38 isolated from an acne patient. Kor J Herbology, (2010). 25(2), 11-9.
41. Seok, SH, Kim, JH, Kim, GW, & Koo, BS. A case of insomnia incurable by neuropsychiatric medication alone, but made possible with Sam-Hwang-Sa-Sim-Tang. J of Oriental Neuropsychiatry, (2006). 17(3), 117-29.
42. Shin, SU, Lee, JS, & Kim, SS. Effect of modified Samhwangsasim-tang(三黃瀉心湯加味方) on Suspicious Dementia of Multiple Infarction Induced by Hypoxia: A Case Report. J Oriental Rehab Med, (2001). 11(2), 219-26.
|
|